Last reviewed · How we verify
NCT04713410
Comparison of Relapse Rate After 12 Weeks Verses 20 Weeks Steroid Therapy for the Management of First Episode of Steroid Sensitive Nephrotic Syndrome
NA trial testing Prednisolone in Steroid-Sensitive Nephrotic Syndrome in 68 participants. Status unknown.
4 September 2022
Quick facts
| Lead sponsor | Shaheed Zulfiqar Ali Bhutto Medical University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 68 |
| Start date | 22 December 2020 |
| Primary completion | 4 September 2022 |
| Estimated completion | 4 September 2023 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Prednisolone — full drug profile →
Conditions studied
- Steroid-Sensitive Nephrotic Syndrome — all drugs for Steroid-Sensitive Nephrotic Syndrome →
Sponsor
Shaheed Zulfiqar Ali Bhutto Medical University
Who can join
Adults 1 to 8, any sex, with Steroid-Sensitive Nephrotic Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
All children from 1 to 8 years of age, diagnose with nephrotic syndrome for the first time will be divided into two groups. One group will be given steroids for 12 weeks and other group will receive steroid for 20 weeks. During the 1 years after completion of steroid course patients will be monitor for the episodes of relapse in both group.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04713410
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Prednisolone
Trials testing the same drug.
- NCT07072585 — Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leuk · Phase 2, PHASE3 · not yet recruiting
- NCT07210008 — "Randomized Controlled Trial Testing the Efficacy of Corticosteroid Therapy Versus Placebo in Fibrotic Hypersensitivity · Phase 3 · not yet recruiting
- NCT06953791 — Comparison of Quality of Life During a Flare of Crohn's Disease Treated With Prednisolone or aCDED With PEN in Adult Pat · Phase 2 · recruiting
- NCT07052929 — Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need Ventilators · Phase 1, PHASE2 · recruiting
- NCT07252271 — Very Low Dose Prednisolone on Newly Diagnosed Rheumatoid Arthritis · Phase 4 · not yet recruiting
Other recruiting trials for Steroid-Sensitive Nephrotic Syndrome
Currently open trials in the same condition.
- NCT05786768 — Efficacy and Safety of Obinutuzumab Versus Rituximab in Childhood Steroid Dependant and Frequent Relapsing Nephrotic Syn · Phase 2, PHASE3 · recruiting
- NCT06065852 — National Registry of Rare Kidney Diseases · recruiting
Other Shaheed Zulfiqar Ali Bhutto Medical University trials
Trials by the same sponsor.
- NCT06525844 — Regenerative Endodontic Therapy in Cases of Irreversible Pulpitis · NA · recruiting
- NCT06176430 — Comparison of Twice Weekly Versus Daily Iron Therapy in Treating Anemia in Children With Cerebral Palsy · Phase 4 · unknown
- NCT06234020 — Frequency of Vertebrospinal Anomalies in Patients Presenting With Anorectal Malformations · completed
- NCT06323642 — Role of Probiotics as Adjunct Therapy Along With Standard Care in Decreasing Hospital Stay and Improving Symptoms in Ped · NA · unknown
- NCT06164158 — Role of Procedural Videos in Teaching the Surgery Residents · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04713410 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shaheed Zulfiqar Ali Bhutto Medical University
- Last refreshed: 11 May 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04713410.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing